We are live on ! Find out more
INVA icon

Innoviva

201 hedge funds and large institutions have $778M invested in Innoviva in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 65 increasing their positions, 81 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more call options, than puts

Call options by funds: $14M | Put options by funds: $5.85M

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

3.94% less ownership

Funds ownership: 76.83%72.89% (-3.9%)

7% less funds holding

Funds holding: 217201 (-16)

20% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 81

31% less capital invested

Capital invested by funds: $1.13B → $778M (-$355M)

47% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 34

Holders
201
Holders Change
-16
Holders Change %
-7.37%
% of All Funds
4.41%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
18
Increased
65
Reduced
81
Closed
34
Calls
$14M
Puts
$5.85M
Net Calls
+$8.17M
Net Calls Change
-$6.2M

INVA Hedge Fund Activity: Q3 2019 in Review

201 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q3 2019, worth a combined $778M — down 31% from $1.13B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of INVA and 18 opened new positions — a net loss of 16 holders — while 81 trimmed existing stakes and 65 added.

The largest buyer was Atom Investors, adding an estimated $6.94M. The largest seller was Wells Fargo, cutting an estimated $18.4M.

  • 201 institutional investors held Innoviva (INVA) as of Q3 2019, down from 217 in Q2 2019.
  • Funds reported $778M of Innoviva stock for Q3 2019, down 31% quarter-over-quarter.
  • 18 funds opened new Innoviva positions in Q3 2019 and 34 closed out, a net change of -16 holders.
  • The largest Innoviva buyer in Q3 2019 was Atom Investors, an estimated $6.94M added.
  • The largest Innoviva seller in Q3 2019 was Wells Fargo, an estimated $18.4M sold.

Based on aggregated 13F filings for Q3 2019.